Biomedical Research and Development Price Index (BRDPI) Survey

Forms and Documents

Document Name	Status
Form Not applicable Biomedical Research and Development Price Index (BRDPI) Survey Form and Instruction	Modified
Supporting statement B, June 14, 2011.doc Supporting Statement B	2011-06-15
Supporting statement A June 14, 2011.doc Supporting Statement A	2011-06-15

IC Document Collections

IC ID	Document Title	Status
3740	Biomedical Research and Development Price Index (BRDPI) Survey Form and Instruction	Modified

ICR Details

OMB Control No: 0608-0069	ICR Reference No: 201106-0608-001
Status: Historical Active	Previous ICR Reference No: 200804-0608-004
Agency/Subagency: DOC/EASA	Agency Tracking No: 200899-0608-100
Title: Biomedical Research and Development Price Index (BRDPI) Survey
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 09/02/2011
	Date Received in OIRA: 07/05/2011
Terms of Clearance: Prior to the commencement of the Biomedical Research and Development Price Index (BRDPI) Survey form mailings, the Bureau of Economic Analysis (BEA) shall provide on its Internet site prominent links to a complete set of finalized survey forms, including instructions and cover letters. The final forms and letters shall reflect any changes in the survey year, OMB number expiration date, and BEA or cooperating partner leadership from those submitted for review.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	09/30/2014	36 Months From Approved	11/30/2011
Responses	150	0	150
Time Burden (Hours)	1,200	0	1,200
Cost Burden (Dollars)	0	0	0

---

Abstract: The survey is used to obtain fiscal year data on expenditures relating to biomedical research and development awards and to update and re-base the BRDPI. Data are obtained from organizations which are recipients of biomedical research and development awards from the National Institutes of Health.

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	76 FR 18517	04/04/2011
30-day Notice:	Federal Register Citation:	Citation Date:
	76 FR 37314	06/27/2011
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
Biomedical Research and Development Price Index (BRDPI) Survey	Not applicable	Biomedical Research and Development Price Index (BRDPI) Survey

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	150	150	0	0	0	0
Annual Time Burden (Hours)	1,200	1,200	0	0	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $80,000

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 07/05/2011

---